Intersect ENT (XENT) Tops Q2 EPS by 3c

Intersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.74 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results